280 related articles for article (PubMed ID: 29747827)
21. B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF.
Ambrosy AP; Fonarow GC; Albert NM; Curtis AB; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW; Gheorghiade M
J Cardiovasc Med (Hagerstown); 2012 Jun; 13(6):360-7. PubMed ID: 22472850
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure.
Feola M; Aspromonte N; Canali C; Ceci V; Giovinazzo P; Milani L; Quarta G; Ricci R; Scardovi AB; Uslenghi E; Valle R
Am J Cardiol; 2005 Sep; 96(5):705-9. PubMed ID: 16125500
[TBL] [Abstract][Full Text] [Related]
23. Increased perioperative b-type natriuretic peptide associates with heart failure hospitalization or heart failure death after coronary artery bypass graft surgery.
Fox AA; Nascimben L; Body SC; Collard CD; Mitani AA; Liu KY; Muehlschlegel JD; Shernan SK; Marcantonio ER
Anesthesiology; 2013 Aug; 119(2):284-94. PubMed ID: 23695172
[TBL] [Abstract][Full Text] [Related]
24. BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial.
Auerbach SR; Richmond ME; Lamour JM; Blume ED; Addonizio LJ; Shaddy RE; Mahony L; Pahl E; Hsu DT
Circ Heart Fail; 2010 Sep; 3(5):606-11. PubMed ID: 20573993
[TBL] [Abstract][Full Text] [Related]
25. Effect of B-Type Natriuretic Peptide Level on Long-Term Outcome in Patients With End-Stage Heart Failure.
Huang B; Shen J; Li L; Huang Y; Luo S
Am J Cardiol; 2016 Aug; 118(3):383-8. PubMed ID: 27269584
[TBL] [Abstract][Full Text] [Related]
26. Towards a multi-marker prognostic strategy in acute heart failure: a role for GDF-15.
Bettencourt P; Ferreira-Coimbra J; Rodrigues P; Marques P; Moreira H; Pinto MJ; Guimarães JT; Lourenço P
ESC Heart Fail; 2018 Dec; 5(6):1017-1022. PubMed ID: 30144302
[TBL] [Abstract][Full Text] [Related]
27. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
[TBL] [Abstract][Full Text] [Related]
28. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.
Hsich EM; Grau-Sepulveda MV; Hernandez AF; Eapen ZJ; Xian Y; Schwamm LH; Bhatt DL; Fonarow GC
Am Heart J; 2013 Dec; 166(6):1063-1071.e3. PubMed ID: 24268222
[TBL] [Abstract][Full Text] [Related]
29. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
[TBL] [Abstract][Full Text] [Related]
31. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
32. Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure.
Sachdeva A; Horwich TB; Fonarow GC
Am J Cardiol; 2010 Sep; 106(6):830-5. PubMed ID: 20816124
[TBL] [Abstract][Full Text] [Related]
33. Distinguishable optimal levels of plasma B-type natriuretic peptide in heart failure management based on complicated atrial fibrillation.
Koitabashi T; Inomata T; Niwano S; Nishii M; Takeuchi I; Nakano H; Shinagawa H; Takehana H; Izumi T
Int Heart J; 2005 May; 46(3):453-64. PubMed ID: 16043941
[TBL] [Abstract][Full Text] [Related]
34. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.
Daniels LB; Clopton P; Bhalla V; Krishnaswamy P; Nowak RM; McCord J; Hollander JE; Duc P; Omland T; Storrow AB; Abraham WT; Wu AH; Steg PG; Westheim A; Knudsen CW; Perez A; Kazanegra R; Herrmann HC; McCullough PA; Maisel AS
Am Heart J; 2006 May; 151(5):999-1005. PubMed ID: 16644321
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).
O'Donoghue M; Kenney P; Oestreicher E; Anwaruddin S; Baggish AL; Krauser DG; Chen A; Tung R; Cameron R; Januzzi JL
Am J Cardiol; 2007 Nov; 100(9):1336-40. PubMed ID: 17950786
[TBL] [Abstract][Full Text] [Related]
36. BNP at discharge in acute heart failure patients: is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status.
Pimenta J; Paulo C; Mascarenhas J; Gomes A; Azevedo A; Rocha-Gonçalves F; Bettencourt P
Int J Cardiol; 2010 Nov; 145(2):209-214. PubMed ID: 19729213
[TBL] [Abstract][Full Text] [Related]
37. B-type natriuretic peptide and impedance cardiography at the time of routine echocardiography predict subsequent heart failure events.
Castellanos LR; Bhalla V; Isakson S; Daniels LB; Bhalla MA; Lin JP; Clopton P; Gardetto N; Hoshino M; Chiu A; Fitzgerald R; Maisel AS
J Card Fail; 2009 Feb; 15(1):41-7. PubMed ID: 19181293
[TBL] [Abstract][Full Text] [Related]
38. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
39. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
Valle R; Aspromonte N; Feola M; Milli M; Canali C; Giovinazzo P; Carbonieri E; Ceci V; Cerisano S; Barro S; Milani L
J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244
[TBL] [Abstract][Full Text] [Related]
40. Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS).
Cleland JGF; Teerlink JR; Davison BA; Shoaib A; Metra M; Senger S; Milo O; Cotter G; Bourge RC; Parker JD; Jondeau G; Krum H; O'Connor CM; Torre-Amione G; van Veldhuisen DJ; McMurray JJV;
Eur J Heart Fail; 2017 Jun; 19(6):739-747. PubMed ID: 28296139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
